FDA: Deregulating During The Pandemic, And Beyond – OpEd
The press has obsessively focused on supposed government shortfalls regarding COVID-19 testing. However, virtually no attention has been given to the Food and Drug Administration’s (FDA’s) vigorous and unprecedented efforts to ease regulatory requirements during the pandemic. One such effort involves “immediately in effect” enforcement policies for medical devices that are particularly needed during this health […]